checkAd

    DGAP-News  579  0 Kommentare Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus


    DGAP-News: Novavax, Inc. /
    Long-Time Novavax Board Member Jack Marsh Assumes Role of Director
    Emeritus

    18.06.2014 / 22:52

    ---------------------------------------------------------------------

    GAITHERSBURG, Md., 2014-06-18 22:52 CEST (GLOBE NEWSWIRE) --
    Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused
    on the discovery, development and commercialization of recombinant nanoparticle
    vaccines and adjuvants, today announced that on June 12, 2014, the Honorable
    John O. Marsh, Jr., resigned as a member of its Board of Directors. Mr. Marsh
    joined the Board of Novavax in August 1991 and served as the company's interim
    CEO and Chairman of the Board from 1996 to 1997. At various times during his 23
    years as a Board member, he has served on all of the Board's various
    committees. According to company records kept since 2005, Jack's attendance
    rate at Board meetings was in excess of 90%; Mr. Marsh has attended every board
    of directors meeting in person or by telephone since 2010. In recognition of
    his 23 years of service, the Board of Directors has named Mr. Marsh Director
    Emeritus.

    A lifetime resident of Virginia, Mr. Marsh served in the U.S. Army during World
    War II and continued with the Army Reserve and Army National Guard into the
    1960s. A graduate of Washington and Lee University Law School, Mr. Marsh began
    practicing law in 1952 in a variety of state and municipal roles. From 1963
    until 1971 he served as a member of the U.S. House of Representatives. In 1973,
    he was appointed Assistant Secretary of Defense, and in January 1974, became
    the National Security Advisor for then Vice President Gerald Ford. He
    subsequently became President Ford's cabinet-ranking Counsellor to the
    President. In 1981, Mr. Marsh was appointed Secretary of the Army by President
    Ronald Reagan where he served until 1989. Mr. Marsh has been awarded the
    Department of Defense Distinguished Public Service Award on six occasions and
    was awarded the Presidential Citizens Medal from President Reagan. Mr. Marsh
    has been a Professor of Law and Ethics at various institutions including the
    Virginia Military Institute, the College of William & Mary, and George Mason
    University. He currently resides in Winchester, Virginia with his wife.

    'Jack's legacy as a board member of Novavax cannot be underestimated. His
    leadership at this company paved the way for our recent years of successful
    vaccine development,' stated Stanley C. Erck, President and CEO. 'Jack's
    enthusiasm for the company's business and his continued presence on the Board
    through some very difficult early years has allowed Novavax to become a leading
    recombinant vaccine development company and to make sustained progress in our
    development of important recombinant vaccine candidates. I am delighted that
    Jack has agreed to serve as a director emeritus to the Board where he can
    continue to mentor and advise the other members of the Board, as well as our
    senior management team.'

    Chairman of the Board James F. Young, Ph.D. stated, 'I am honored and
    privileged to have served on the Novavax Board of Directors with Jack Marsh.
    Over the last four years, I have learned a great deal about the company's
    history and about boardroom decision-making and diplomacy, witnessing Jack's
    firm and confident presence in our boardroom. I am proud to call Jack a friend,
    and I look forward to working with him in the future.'

    About Novavax

    Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
    creating vaccines and vaccine adjuvants to address a broad range of infectious
    diseases worldwide. Using innovative proprietary recombinant nanoparticle
    vaccine technology, the company produces vaccine candidates to efficiently and
    effectively respond to both known and newly emergent diseases.


    CONTACT: Barclay A. Phillips
    SVP, Chief Financial Officer and Treasurer
    Novavax, Inc.
    240-268-2000
    News Source: NASDAQ OMX


    End of Corporate News

    ---------------------------------------------------------------------

    18.06.2014 Dissemination of a Corporate News, transmitted by DGAP - a
    company of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    DGAP's Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de

    ---------------------------------------------------------------------


    Language: English
    Company: Novavax, Inc.


    United States
    ISIN: US6700021040


    End of News DGAP News-Service
    ---------------------------------------------------------------------
    274357 18.06.2014


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus DGAP-News: Novavax, Inc. / Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus 18.06.2014 / 22:52 --------------------------------------------------------------------- GAITHERSBURG, Md., 2014-06-18 22:52 CEST (GLOBE NEWSWIRE) …

    Schreibe Deinen Kommentar

    Disclaimer